Nomura Holdings’s Corcept Therapeutics CORT Stock Holding History

Nomura Holdings’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,509	Closed	-$2.34M	–	1542
2025 Q1	$2.34M	Buy	+20,509	New	+$1.25M	﹤0.01%	994
2021 Q2	–	Sell	-23,159	Closed	-$550K	–	2063
2021 Q1	$550K	Buy	+23,159	New	+$618K	﹤0.01%	1316
2016 Q3	–	Sell	-14,213	Closed	-$75K	–	1209
2016 Q2	$75K	Buy	14,213 +100	+0.7%	+$520	﹤0.01%	1128
2016 Q1	$65K	Buy	+14,113	New	+$55K	﹤0.01%	1432
2015 Q4	–	Sell	-25,114	Closed	-$90K	–	1877
2015 Q3	$90K	Sell	25,114 -13,661	-35%	-$69.3K	﹤0.01%	1515
2015 Q2	$218K	Buy	38,775 +2,477	+7%	+$15.2K	﹤0.01%	1571
2015 Q1	$191K	Buy	+36,298	New	+$131K	﹤0.01%	1525
2014 Q3	–	Sell	-78,097	Closed	-$213K	–	2803
2014 Q2	$213K	Buy	+78,097	New	+$230K	﹤0.01%	2345

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nomura Holdings's CORT Position: Q2 2025 in Review

Nomura Holdings sold out of Corcept Therapeutics (CORT) in Q2 2025, closing a stake of 20,509 shares — an estimated $2.34M sold.

Nomura Holdings first reported a position in CORT in Q2 2014 and held it in 8 quarters. The position peaked at $2.34M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

Nomura Holdings reported no remaining Corcept Therapeutics position as of Q2 2025 after selling out during the quarter.
Nomura Holdings sold 20,509 Corcept Therapeutics shares in Q2 2025, an estimated $2.34M.
Nomura Holdings first reported a position in Corcept Therapeutics in Q2 2014 and held it in 8 quarters.
Nomura Holdings's Corcept Therapeutics position peaked at $2.34M in Q1 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.